News | November 07, 2014

First Implant of Solo Smart in the U.S.

Solo Smart, the first aortic tissue valve with a removable stent, was successfully implanted in the first U.S. patient

Sorin Group, heart valve repair, first implant

Nov. 7, 2014 — Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, implanted the Solo Smart surgical replacement performed by David Heimansohn, M.D., at St. Vincent’s Heart Hospital in Indianapolis, Ind.

Solo Smart is the first and only valve with a removable stent to be approved in the U.S. market. This unique bioprosthesis, made from bovine pericardium, has no synthetic material added, allowing it to mimic the healthy native aortic valve. Solo Smart maximizes blood flow and delivers excellent hemodynamic performance, while providing the ease of implantability of a stented valve.

Solo Smart is the next generation of the Freedom Solo valve, which has been available in Europe since 2004.

For more information: www.sorin.com

Related Content

First TriCinch Coil Tricuspid Repair Systems Implanted in U.S.
News | Heart Valve Technology | November 06, 2018
4Tech Inc. initiated its U.S. Early Feasibility Study of the TriCinich Coil System following U.S. Food and Drug...
Valve Replacement Volume Key to Successful Patient Outcomes
News | Heart Valve Technology | November 02, 2018
Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are more likely to...
Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and...
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (...
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally...
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study...
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc.
Gore Acquires Pipeline Medical Technologies Inc.
News | Heart Valve Technology | September 06, 2018
W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc., a privately...
Overlay Init